DDIT3 and diffuse large B-cell lymphoma: DLBCL has since been classified under 2 main groups, the germinal center type (GC) and the activated B-cell type (ABC).9 The first group (GC) resembles a normal germinal center B cell and has a superior rate of 5-year survival with current therapy (CHOP or R-CHOP), whereas the second group resembles an activated B cell and is associated with inferior rates of 5-year survival.